Alcentra Capital Corp (NASDAQ:ABDC) – Stock analysts at Oppenheimer increased their Q1 2019 EPS estimates for Alcentra Capital in a research note issued to investors on Tuesday, March 12th. Oppenheimer analyst C. Kotowski now anticipates that the asset manager will post earnings of $0.21 per share for the quarter, up from their prior estimate of $0.20. Oppenheimer also issued estimates for Alcentra Capital’s Q2 2019 earnings at $0.20 EPS, Q3 2019 earnings at $0.20 EPS, Q4 2019 earnings at $0.20 EPS, FY2019 earnings at $0.82 EPS, Q1 2020 earnings at $0.20 EPS, Q2 2020 earnings at $0.21 EPS, Q3 2020 earnings at $0.22 EPS, Q4 2020 earnings at $0.22 EPS and FY2020 earnings at $0.84 EPS.
Alcentra Capital (NASDAQ:ABDC) last announced its earnings results on Monday, March 11th. The asset manager reported $0.27 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.05. The company had revenue of $6.98 million for the quarter, compared to analysts’ expectations of $6.62 million. Alcentra Capital had a return on equity of 9.14% and a net margin of 19.06%.
Shares of NASDAQ:ABDC opened at $7.63 on Thursday. The company has a market cap of $104.10 million, a P/E ratio of 7.55 and a beta of 0.56. Alcentra Capital has a 12-month low of $5.58 and a 12-month high of $7.82.
The business also recently announced a quarterly dividend, which will be paid on Thursday, April 4th. Investors of record on Friday, March 29th will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $0.72 annualized dividend and a dividend yield of 9.44%. Alcentra Capital’s payout ratio is 71.29%.
Several large investors have recently made changes to their positions in ABDC. Bank of New York Mellon Corp boosted its position in shares of Alcentra Capital by 17.6% during the second quarter. Bank of New York Mellon Corp now owns 629,022 shares of the asset manager’s stock valued at $4,019,000 after buying an additional 94,111 shares during the last quarter. Mackenzie Financial Corp boosted its position in shares of Alcentra Capital by 73.1% during the third quarter. Mackenzie Financial Corp now owns 69,744 shares of the asset manager’s stock valued at $417,000 after buying an additional 29,458 shares during the last quarter. Virtu Financial LLC purchased a new position in shares of Alcentra Capital during the fourth quarter valued at approximately $90,000. Stilwell Value LLC boosted its position in shares of Alcentra Capital by 16.9% during the fourth quarter. Stilwell Value LLC now owns 1,101,491 shares of the asset manager’s stock valued at $7,127,000 after buying an additional 159,140 shares during the last quarter. Finally, Two Sigma Investments LP purchased a new position in shares of Alcentra Capital during the fourth quarter valued at approximately $265,000. 28.42% of the stock is currently owned by institutional investors.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.
Further Reading: SEC Filing
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.